Baseline characteristics | Total n = 810 | Participants without neuropathy n = 742 | Participants with Primary open-angle glaucoma n = 68 | P |
---|---|---|---|---|
Age, years | 82.11 ± 3.67 | 81.99 ± 3.62 | 83.36 ± 4.07 | 0.003 |
Sex | ||||
 Male | 292 (36.05) | 266 (35.85) | 26 (38.24) | 0.695 |
Smoking status, yes, n = 96 | 282 (35.43) | 257 (35.16) | 25 (38.46) | 0.594 |
Alcohol consumption, yes, n = 730 | 46 (6.30) | 44 (6.58) | 2 (3.28) | 0.312 |
Body mass index, > 25 kg/m2 | 379 (46.79) | 348 (46.90) | 31 (45.59) | 0.836 |
Diabetes, n = 729 | 66 (9.05) | 58 (8.68) | 8 (13.11) | 0.248 |
Diabetic retinopathy | 7 (0.86) | 7 (0.94) | 0 (0.00) | Â |
Age-related maculopathy degeneration (AMD) stage, n = 753 |  |  |  | 0.530 |
 No AMD | 412 (54.71) | 381 (55.14) | 31 (50.00) |  |
 Early AMD stage 1 | 235 (31.21) | 213 (30.82) | 22 (35.48) |  |
 Early AMD stage 2 | 78 (10.36) | 71 (10.27) | 7 (11.29) |  |
 Early AMD stage 3 | 15 (1.99) | 15 (2.17) | 0 (0.00) |  |
 Late AMD | 13 (1.73) | 11 (1.59) | 2 (3.23) |  |
Intraocular pressure, mmHg | 15.49 ± 3.32 | 15.46 ± 3.32 | 15.81 ± 3.35 | 0.407 |
Cup/Disc Ratio, n = 780 | 0.36 ± 0.22 | 0.32 ± 0.19 | 0.74 ± 0.09 | < 0.0001 |
Mean deviation of visual field, dB, n = 783 | −11.69 ± 8.12 | NA | −11.69 ± 8.12 | NA |
Axial length, μm, n = 664 | 23.44 ± 1.30 | 23.39 ± 1.24 | 23.88 ± 1.77 | 0.006 |
Antihypertensive treatment, n = 730 | 442 (60.55) | 400 (59.79) | 42 (68.85) | 0.166 |
Lipid lowering drug use, n = 730 | 331 (42.60) | 283 (42.30) | 28 (45.90) | 0.586 |
Plasma total cholesterol, mmol/l | 5.80 ± 0.96 | 5.81 ± 0.97 | 5.82 ± 0.75 | 0.921 |
Low density lipoprotein, mmol/l | 3.61 ± 0.84 | 3.60 ± 0.86 | 3.65 ± 0.69 | 0.650 |
High density lipoprotein, mmol/l | 1.67 ± 0.40 | 1.67 ± 0.39 | 1.64 ± 0.43 | 0.567 |
Triglycerides, mmol/l | 1.17 ± 0.50 | 1.17 ± 0.51 | 1.15 ± 0.43 | 0.781 |